Accurate prediction of CDR-H3 loop structures of antibodies with deep learning.

Journal: eLife
PMID:

Abstract

Accurate prediction of the structurally diverse complementarity determining region heavy chain 3 (CDR-H3) loop structure remains a primary and long-standing challenge for antibody modeling. Here, we present the H3-OPT toolkit for predicting the 3D structures of monoclonal antibodies and nanobodies. H3-OPT combines the strengths of AlphaFold2 with a pre-trained protein language model and provides a 2.24 Å average RMSD between predicted and experimentally determined CDR-H3 loops, thus outperforming other current computational methods in our non-redundant high-quality dataset. The model was validated by experimentally solving three structures of anti-VEGF nanobodies predicted by H3-OPT. We examined the potential applications of H3-OPT through analyzing antibody surface properties and antibody-antigen interactions. This structural prediction tool can be used to optimize antibody-antigen binding and engineer therapeutic antibodies with biophysical properties for specialized drug administration route.

Authors

  • Hedi Chen
    School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China.
  • Xiaoyu Fan
    Department of Orthopedics, Beijing Key Laboratory for Immune-Mediated Inflammatory Diseases, China-Japan Friendship Hospital, Peking Union Medical College, Beijing 100029, China; China-Japan Friendship Hospital, Peking University, Beijing 100029, China.
  • Shuqian Zhu
    MOE Key Laboratory of Bioinformatics, State Key Laboratory of Molecular Oncology, School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
  • Yuchan Pei
    Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing, China.
  • Xiaochun Zhang
    Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Fudan University, Shanghai, 200032, China.
  • Xiaonan Zhang
    Department of Natural Language Processcing, Baidu International Technology (Shenzhen) Co., Ltd, Shenzhen 518000, China.
  • Lihang Liu
    Department of Natural Language Processcing, Baidu International Technology (Shenzhen) Co., Ltd, Shenzhen 518000, China.
  • Feng Qian
    Department of Neurosurgery, Anhui No. 2 Provincial People's Hospital, Hefei, Anhui, China.
  • Boxue Tian
    School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China.